Toby K. McGovern

Toby K. McGovern

Auto-generated profile, based on publicly available information

Toby K. McGovern

Meakins-Christie Laboratories, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Journal of Immunology Research
Verified
Journal Article
Open access
OKOsama Kishta
Osama Kishta
ASAntoine Sabourin
Antoine Sabourin
LSLeora Simon
Leora Simon
TMToby McGovern
Toby McGovern
MRMaxime Raymond
Maxime Raymond
JTJacques Thibodeau
Jacques Thibodeau
Membrane-associated RING-CH-1 (March1) is a member of the March family of E3 ubiquitin ligases. March1 downregulates cell surface expression of MHC II and CD86 by targeting them to lysosomal degradation. Given the key roles of MHC class II and CD86 in T cell activation and to get further insights into the development of allergic inflammation, we asked whether March1 deficiency exacerbates or attenuates features of allergic asthma in mice. Herein, we used an acute model of allergy to compare the asthmatic phenotype of March1-deficient and -sufficient mice immunized with ovalbumin (OVA) and later challenged by intranasal instillation of OVA in the lungs. We found that eosinophilic inflammation in airways and lung tissue was similar between WT and March1−/− allergic mice, whereas neutrophilic inflammation was significant only in March1−/− mice. Airway hyperresponsiveness as well as levels of IFN-γ, IL-13, IL-6, and IL-10 was lower in the lungs of asthmatic March1−/− mice compared to WT, whereas lung levels of TNF-α, IL-4, and IL-5 were not significantly different. Interestingly, in the serum, levels of total and ova-specific IgE were reduced in March1-deficient mice as compared to WT mice. Taken together, our results demonstrate a role of March1 E3 ubiquitin ligase in modulating allergic responses.

27 September 2024 in Science Advances
Verified
Journal Article
Open access
JCJulia Chronopoulos
Julia Chronopoulos
EPErwan Pernet
Erwan Pernet
KTKim A. Tran
Kim A. Tran
TMToby K. McGovern
Toby K. McGovern
AMArina Morozan
Arina Morozan
JMJames G. Martin
James G. Martin
Pregnancy is associated with profound changes in immunity. However, pregnancy-related respiratory immune adaptations in response to influenza infection and their impact on disease severity remain unclear. Here, we describe, in a preclinical model of mid-gestation pregnancy, a mechanism of enhanced host defense against influenza A virus (IAV) localized to the nasal cavity that limits viral replication and reduces the magnitude of intrapulmonary immune responses. Consequently, the pregnant mice show reduced pulmonary pathology and preserved airway function after IAV infection. The early restriction of viral replication is independent of type I interferon (IFN) but dependent on increased antimicrobial peptides (AMPs) driven by interleukin-17 + (IL-17 + ) γδ + T cells within the nasal passages. This pathway of host defense against IAV infection in the upper airways during pregnancy restricts early viral infection and prevents virus dissemination into the lung supporting maternal fitness.

1 November 2015 in Respiratory Physiology & Neurobiology
Verified
Journal Article
Closed access
MNMauro Novali
Mauro Novali
KSKarim H. Shalaby
Karim H. Shalaby
ARAnnette Robichaud
Annette Robichaud
ABAndrea Benedetti
Andrea Benedetti
LFLiah Fereydoonzad
Liah Fereydoonzad
JMJames G. Martin
James G. Martin